+100%-
 
With the Phase III trials looming, the results of Dr. Pridgen’s phase II clinical trials on his antiviral approach to fibromyalgia have been released.
 
His next step – finding a way through the “valley of death” where many drug possibilities go to die – and launch the Phase III trials needed for the FDA drug approval. Find out what Dr. Pridgen thought of the last trial and how he’s getting ready for the next in a Simmaron Research Foundation sponsored blog…
 

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest

Share This